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Objectives: To evaluate the influence of clindamycin, given alone or with Lactobacillus delbrueckii and Streptococcus 
thermophilus to conventional rats, on 7a-dehydroxylation of cholic acid to deoxycholic acid. 
Methods: The presence of deoxycholic acid was determined by gas-liquid chromatography. The fecal concentration 
of clindamycin was determined on PDM antibiotic sensitivity medium. Colony-forming units of L. delbrueckii and 
S. thermophilus were counted on lactic acid bacteria agar, and their ability to deconjugate was determined by thin-layer 
chromatography. 
Results: Clindamycin significantly reduced the formation of deoxycholic acid, while the administration of lactobacilli- 
streptococci at the same time significantly reduced the effect of the antibiotic (p<0.05). 
Conclusions: Clindamycin reduced the formation of deoxycholic acid in rats and this effect was diminished by 
concomitant administration of L. delbrueckii and S. therrnophilus. As the given microbes could not 7a-dehydroxylate, it 
seems reasonable to assume that they stimulate microbial species already present in the intestine. 
Key words: Lactobacillus delbrueckii, Streptococcus therrnophilus, microflora-associated characteristics, bile acid, 
clindamycin, germ-free 
INTRODUCTION 
The intestinal niicroflora plays important regulatory 
and protective roles in mammals. An ecosystem develops 
shortly after birth, and throughout life it is influenced 
by various endogenous and exogenous factors [ 1-31. 
Antimicrobial treatment may greatly affect the micro- 
flora and disturb many of its functions or so-called 
microflora-associated characteristics (MACs) [4-61. An 
MAC is defined as the recording of any anatomic 
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structure or physiologic, biochemical or immunologic 
function in a macroorganism which has been affected 
by the microflora. When microbes that influence the 
parameter under study are absent, as in germ-free 
animals, in newborn babies and after certain types of 
antibiotic therapy, the recordings are defined as gerni- 
free animal characteristics (GAG) [6]. 
Various food supplements have been used for 
many years to protect and maintain the balance in 
the intestinal ecosystem of anirnals and humans (7-101. 
Some of these supplements can be classified as probiotics: 
a probiotic was defined by Fuller in 1989 as ‘a live 
niicrobial feed supplement which beneficially affects 
the host animal by improving its intestinal microbial 
balance’ [lo]. 
In earlier studies we have shown that admini- 
stration of antibiotics to humans and rats markedly 
affected several M A G ;  clindamycin had the most 
pronounced effect [l l-171. In healthy volunteers, the 
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excretion of secondary bile acids (7~-dehydroxylated 
derivatives) decreased to one-third (median) of the 
initial value after they were given clindamycin for 6 
days [11,18]. The aim of the present study was to 
determine, in an animal model, whether co-admini- 
stration of clindamycin and lactobacilli-streptococci 
(LS) could modify this effect. In addition, the abdity of 
the two strains to deconjugate bile acids in vitro and 
their susceptibility against clindamycin was studied. 
MATERIALS AND METHODS 
Rats 
Adult conventional AGUS rats of both sexes were 
fed a commercially available sterilized animal diet and 
water ad libitum [12,19]. 
Lactobacillus and Streptococcus 
Aliquots of commercially obtained spray-dried powder 
of Lactobacillus delbrtreckii subsp. bulgaricus (DSM 20081) 
and Streptococcus thermophilus (ATCC 19258) were 
dissolved daily in sterile 1 /4-strength thiosulfate Ringer 
solution (Oxoid, Basingstoke, 1JK) to a final concen- 
tration of lo8 colony-forming units (CFU)/mL. 
Antibiotic 
Clindamycin (Dalacin, Upjohn) was dissolved daily in 
water (2 mg/mL). 
Design of the study 
Twenty rats were randomly divided into four groups of 
five rats each and kept in individual metabolism cages, 
1 week before and during the observed period of 24 
days. The cages were placed in two racks in an ordinary 
animal facility with a temperature of 24 k 2"C, a relative 
humidity of 55 k 10% and controlled light. The study 
was approved by the local ethics committee. 
The animals were treated for 6 days and were 
given, via a stomach tube, 1 mL of distilled water each 
day or clindamycin in the morning and water or LS at 
noon, according to the following regimen. 
Group W (water) 
Water was given twice a day. 
Group LS 
Water was given in the morning and LS suspension at 
noon. 
Group C (clindamycin) 
In the morning, clindamycin solution, corresponding 
to 4 mg/kg body weight, was given for 5 days (day 0 
to day 4) and water at noon (day 0 to day 4). Water was 
given twice on day 5. 
Group CLS (clindamycin, lactobacilli and streptococci) 
Clindamycin solution (4 mg/kg body weight) was given 
in the morning for 5 days (day 0 to day 4) and water 
on day 5. LS suspension was given at noon for 6 days 
(day 0 to day 5). 
All animals were handled by trained personnel in the 
same sequence: W, LS, C and CLS. Separate gloves 
were used when handling rats from the different 
groups, to reduce the risk of transferring bioactive 
material between the groups. 
Fecal samples were collected in the daytime twice 
during the week before, on day 0, twice during the 
treatment and thereafter once a week. The feces were 
frozen at -20°C within 1 h after defecation and kept 
frozen pending analysis. On day 4, a fecal sample was 
taken from each rat in groups C and CLS for deter- 
minations of the concentration of clindamycin. 
Analysis of bile acids 
The fecal samples were analyzed by gas-liquid chroma- 
tography (GLC) [l]. The conversions of both cholic 
acid to deoxycholic acid (DCA) and chenodeoxycholic 
acid to lithocholic acid were followed. The presence or 
absence of DCA in the samples was noted. 
Deconjugation in vitro 
An overnight culture of L. delbrueckii subsp. bulgaricus, 
0.5 mL, was added to MRS broth (Merck, Darmstadt, 
Germany), and of S. thermophilus to Todd Hewitt broth 
(Difco, Detroit, Michigan, USA). Each medium was 
supplemented with 2.5 mM taurodeoxycholic acid. 
After anaerobic incubation for at  least 72 h at 37OC, the 
presence of DCA was determined with GLC [l]. 
Deconjugation was determined with thin-layer chroma- 
tography (TLC) [20]. 
Determination of lactobacilli and streptococci 
Fresh feces were homogenized in sterile 1/4-strength 
thiosulfate Ringer's solution (1 : lO)  with an Ultra 
Turrax homogenizer; this was followed by 1 0-fold 
dilutions in triplicates. Lactic acid bacteria were counted 
by utilizing a technique described earlier [12]. 
The susceptibility against clindamycin was deter- 
mined by Etest (AB Biodisk, Solna, Sweden) on blood 
agar (S. tkermophilrrs) and MRS (L. delbrueckii). Stan- 
dardized inocula (0.5 McFarland) were utilized and 
the plates were incubated anaerobically at 37OC for 
48 h. 
Analysis of clindamycin 
The concentration of clindamycin in feces was deter- 
mined according to Carlstedt-Duke et a1 [12]. 
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Statistical evaluation 
The log values of the LS CFUs were analyzed with the 
Student's t-test (p<0.05). The presence or absence of 
D C A  during the period 5-24 days was evaluated with 
the chi-square test (p<0.05). 
Lactobacilli-streptococci 
In group W, the number of LS remained unchanged 
throughout the study and administration of clinda- 
mycin had no effect (Table 1). 
The groups receiving LS showed a tendency to 
higher value4 on day 5 (CLS) and day 10 (LS) than 
Animals 
All the rats were healthy during the study and their 
weights remained relatively constant (230 g). None of 
them developed diarrhea, although all those on clinda- 
mycin, independently of the LS treatment, had feces of 
slightly looser consistency than the rats in the other 
groups. 
7a-Dehydroxylation 
In all rats, DCA was found before the treatment, and 
7ia-dehydroxylating activity was present in all samples 
from rats in the W and LS groups throughout the study. 
No D C A  was detected on day 5 in 8 of I0 rats in groups 
C 2nd CLS, and the remaining two rats had a reduction 
to about half of the initial value. This effect persisted 
during the observation period in one rat in group C, 
and 7ia-dehydroxylation was not re-established within 
24 days. 
Figure 1 shows the percentage of observations 
made from day 5 (the last day of clindamycin treatment) 
to day 24 in the different groups. The percentage with 
no formation of D C A  was significantly lower (p < 0.05) 
in group CLS (22%) than in group C (50%). There was 
also a significant difference between group CLS and the 
W and LS groups (p<0.05). 
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Figure 1 DCA was present in all raniples from groups W 
and LS during the period 5-24 dayc. The percentages of 
observations with no detectable DCA (black) during this 
period are given. *Significant differences ( p  < 0.05) were 
found between group W or LS and group C, group W or 
LS and group CLS, and between groups C and CLS. The 
number of observations for the various groups are given in 
parentheses. 
Table 1 Number of lactobacilli-streptococci found in fecal samples after treatment 
Clindarnycin" 
afier 4 day? No. of LS No. ofLS No. of LS No. of LS 
Group before treatmentb after 5 days" after 1 0  dayyh after 17 daysh ( m g / k )  
w 
Median 1 i x l ( ) "  O..i x 1 0' I 1  7x1(1" 1 .2X I f ) ' ~  
Range 0.8X10' to 2.8X10' 0.4X109 to 3.SXlO' O.Sx10" to 1.3x10" 0.7xlO" to 1 . 7 ~ 1 0 "  
Medlan 1. I x10~ 1 x10' 1 x 10"' l . l X l ( f '  
Range 0 . 8 ~ 1 0 ~  to 1 . 3 ~ 1 0 ~  0 . 3 ~ 1 0 "  to 2 . 6 ~ 1 0 '  1 1 . 7 x i n ~ ~ '  to i . 8 x i o l r 1  i i . 7 ~ 1 0 ' ~  tO i.f,xio'j 
Median 1.1 x 10" 3.SX10' 
Range 0 . 9 ~ 1 0 ~  to 15x10" 1x10" to 7x10' 0.7 x 1 0" to 4 x 1 0" 3 X l l P  to I 2 X l O "  8-75 
Median 1 XIO' 4.5XlO~' 7x10' I .j x 10" 41 I 
LS 
c: 
53 - 7 -  I .3  X I  (08 1 .s x 10" 
CLS 
K'mge i).8XIO" to 2x10' 2x109 to 1.6~1010 ~.SXIO* to 2 .sx io "  o .3x io ' l  tO 4 x i o "  19-53 
'Clindaniycin found in frcal samples taken after 4 days. 
"Mean values for each of three animals in each group. 
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group W After 17 days, all individual rats showed about 
the same levels of LS as before the study, regardless of 
treatment. 
The strains were sensitive to clindamycin, and 
the inhibitory concentrations were 0.032 mg/L (L. 
delbrueckii] and 0.38 mg/L (S. thermophilus). 
Deconjugation 
No DCA was found in the i n  vitro tests (data not 
shown). 
Antibiotics 
The median value of clindamycin in group C was 
53 mg/kg (range 8-75 mg/kg). In group CLS, the 
median value was 40 mg/kg (range 19-53 mg/kg) 
(Table 1). 
DISCUSSION 
We found that administration of clindamycin markedly 
inhibits 7a-dehydroxylation in rats. These findings are 
in agreement with previous results in humans [I 11. 
Dehydroxylating activity is mostly carried out by 
strictly anaerobic members of the intestinal flora, and 
clindamycin has pronounced activity against most 
anaerobes [16]. The great effect of clindamycin on the 
intestinal microflora may facilitate the activity of 
microbes which are unaffected by this antibiotic. In 
some previous studies, we found that clindamycin 
influenced several other MACs, such as degradation 
of mucin, inactivation of tryptic activity, formation 
of coprostanol and short-chain fatty acids (SCFA) and 
the presence of P-aspartylglycine in humans and 
animals [ll-13,15-17, 211. 
Our results also show that oral suspensions of 
LS significantly reduced the influence of clindamycin 
on 7a-dehydroxylation. Despite the presence of 
clindamycin, L and S opened niches for microbial 
7a-dehydroxylation and thus have a probiotic effect. 
A similar probiotic effect could not be demonstrated 
when the other MACs mentioned above were investi- 
gated [12,22]. The mechanism underlying the probiotic 
effect is uncertain. L and S were detected in the 
presence of clindamycin at an almost unchanged level 
during the study (Table 1). The highest number of L 
and S was found on day 5 (CLS:) and day 10 (LS) in the 
groups receiving the LS suspension. The mere facts that 
both LS strains were highly susceptible to clindamycin 
and that ingestion of clindarnycin had hardly any 
influence on the number of these microbes indicate 
that the effect of clindamycin is related not to the added 
LS suspension but to alterations in the microflora 
already present. 
This assumption may be further substantiated as 
follows. First, LS showed no ability to deconjugate. It 
is generally assumed that conjugates of cholic acid and 
chenodeoxycholic acid must be deconjugated before 
the removal of the hydroxyl group at position C-7 can 
occur [23]. However, it is well established that several 
strains of Lmtobacillus, Streptococcus and Bijdobacterium, 
as well as other anaerobes, can deconjugate bile acids 
[18,23,24]. Mice colonized by L. delbrueckii 18 and 21 
and L. fermenturn 20 had more bile salt hydrolase activity 
in the intestinal tract than lactobacillus-free mice, and 
the proportion of unconjugated bile acids in the small 
bowel contents was significantly greater [25]. 
Second, the strains used in the present study do not 
belong to the relatively small group of microbial species 
known to be able to perform 7a-dehydroxylation 
[18,23,26]. In a study on ileostomy subjects, excretion 
of free secondary bile acids increased significantly 
during ingestion of fermented mdk containing Bijdo- 
bacterium and L. acidophilus [27]. These strains could 
deconjugate but not dehydroxylate bile acids in vitro. 
To the best of our knowledge, it has never been 
satisfactorily shown that any bacterial strain belonging 
to species utilized in fermented products can dehydrox- 
ylate bile acids. 
O n  the whole, it seems reasonable to assume that 
LS exert their effects by stimulating microbial species 
already present in the intestine. The fact that the effects 
on intestinal bile acid metabolism occur independently 
of the strain’s ability to perform the reactions under 
study shows the importance of evaluating many factors 
and functions before a probiotic is introduced. 
It is well established that antibiotic treatment may 
have major effects in humans on deconjugation and 
7a-dehydroxylation of bile acids [I 1,28,29]. Whether 
and to what extent administration of probiotics may 
influence these effects and their clinical aspects have to 
be further evaluated. 
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